Bridge Biotherapeutics : 30% or More Change in Sales or Profit/Loss(15% or more in the case of large-scale corporations)

30% or More Change in Sales or Profit/Loss(15% or more in the case of large-scale corporations)

1. Type of Financial Statements	Consolidated Financial Statements
2. Details of Changes in Sales or Profit/Loss (KRW)	Current Fiscal Year	Previous Fiscal Year	Amount Increased/ Decreased	Increase/ Decrease Rate (%)
- Sales(Limited to the amount of Revenue according to sales of goods and services provided)	1,924,158,150	6,339,946,467	-4,415,788,317	-70.00
- Operating Income	-26,391,767,980	-19,578,220,215	-6,813,547,765	-35.00
- Profit from continuing operation before corporate income tax	-26,278,291,392	-19,232,492,177	-7,045,799,215	-37.00
- Net Income	-26,278,291,392	-19,232,492,177	-7,045,799,215	-37.00
- Applicability of Large-scale Corporation	No
3. Financial Status (KRW)	Current Fiscal Year	Previous Fiscal Year
- Total Assets	46,657,249,917	63,510,099,312
- Total Liabilities	3,609,930,975	4,282,024,005
- Total Shareholders' Equity	43,047,318,942	59,228,075,307
- Capital Stock	9,853,712,500	9,590,587,000
4. Main Reasons for Changes in Sales or Profits/Losses	1. Reasons for changes in sales. Earnings fluctuation due to the company's business model 2. Reasons for profit and loss change. Increase in R&D expenditure due to development advancements of the company's pipeline assets Increase in stock-based compensation costs. - Stock options granted to new R&D employees - Stock donation by the majority shareholder to the employee stock ownership association
5. Date Of Board Of Directors Resolution(Decision Date)	2022-03-07
- Attendance of Outside Directors	Present(No.)	3
Absent(No.)	-
- Attendance of Auditors(members of Audit Committee)	-
6. Other references concerning investment decisions	1. The consolidated financial statement for the current business year (2021) are based on K-IFRS 2. The consolidated financial statements for the previous business year (2020) are based on the consolidated audit report from the same year. 3. The contents above are subject to change after the external audit and the Annual General Meeting of Shareholders.
※Relevant Disclosure	-
Note that this disclosure includes the un-audited information and some of the details may be changed according to the audit results